Sponsor overview

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 1

Watchlist assets: 1

Registry stop assets: 1

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT05912205 | https://clinicaltrials.gov/study/NCT06157892 | https://clinicaltrials.gov/study/NCT06105008 | https://clinicaltrials.gov/study/NCT06966453 | https://clinicaltrials.gov/study/NCT06210490 | https://clinicaltrials.gov/study/NCT07366840 | https://clinicaltrials.gov/study/NCT06003231

Assets

Linked programs

Disitamab Vedotin: Registry Stop Signal (5/5)